K

Kallyope

99 employees

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Basic info

Industry

biotechnology research

Sectors

Neurology
Biotechnology
Health Care
Gut-Brain Axis
Gastrointestinal Disease
Medical
Pharmaceutical
Metabolism
Pharmaceuticals

Date founded

2015

Funding rounds raised

Total raised

$236M

from 30 investors over 30 rounds

K

Kallyope raised $8.2M on May 10, 2023

Investors: Bill & Melinda Gates Foundation

K

Kallyope raised $236M on February 15, 2022

Investors: The Column Group, Tao Capital Partners, Two Sigma Ventures, StepStone Group, Parkwood LLC, Polaris Partners, Lux Capital and Illumina Ventures

K

Kallyope raised $112M on March 5, 2020

Investors: Greenspring Associates, Casdin Capital, LLC, Illumina Ventures, Lux Capital, Two Sigma Ventures, Polaris Partners and The Column Group

K

Kallyope raised $21M on December 5, 2018

Investors: Lux Capital, Illumina Ventures, The Column Group, Two Sigma Ventures and Polaris Partners

K

Kallyope raised $66M on February 22, 2018

Investors: The Column Group, Two Sigma Ventures, Lux Capital, Illumina Ventures and Polaris Partners

K

Kallyope raised $44M on December 10, 2015

Investors: The Column Group, Polaris Partners, Illumina Ventures and Lux Capital

FAQ